These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17965485)

  • 21. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
    Akbulut M; Ozbay Y; Karaca I; Ilkay E; Gundogdu O; Arslan N
    Coron Artery Dis; 2004 Sep; 15(6):347-52. PubMed ID: 15346093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
    Schleinitz MD; Olkin I; Heidenreich PA
    Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of paclitaxel-eluting stents on restenosis].
    Kurşaklioğlu H; Köz C; Iyisoy A; Ide T; Yildirim V; Töre HF; Işik E; Demirtaş E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):18-23. PubMed ID: 16524795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.
    Ahn JC; Song WH; Kwon JA; Park CG; Seo HS; Oh DJ; Rho YM
    Korean J Intern Med; 2004 Dec; 19(4):230-6. PubMed ID: 15683111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neointima in coronary stent does not increase during over 1-year in non-restenosed lesion at 6 months follow-up: serial volumetric intravascular ultrasound study.
    Suzumura H; Suzuki T; Hosokawa H; Fukutomi T; Ito S; Itoh M
    Jpn Heart J; 2002 Nov; 43(6):581-91. PubMed ID: 12558123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
    Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
    Nakamura S; Hall P; Gaglione A; Tiecco F; Di Maggio M; Maiello L; Martini G; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):21-7. PubMed ID: 8996290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
    Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Staico R; Feres F; Centemero M; Tanajura LF; Abizaid A; Pinto I; Maldonado G; Seixas A; Costa MA; Paes A; Mintz GS; Sousa JE
    Circulation; 2004 Feb; 109(7):861-6. PubMed ID: 14757690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention.
    Kim JY; Lee K; Shin M; Ahn M; Choe H; Yoo BS; Yoon J; Choe KH; Lee SH
    Circ J; 2007 Dec; 71(12):1867-72. PubMed ID: 18037738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study.
    Dudek D; Legutko J; Heba G; Bartus S; Partyka L; Huk I; Dembinska-Kiec A; Kaluza GL; Dubiel JS
    Am Heart J; 2004 Apr; 147(4):E12. PubMed ID: 15077095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
    Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
    Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study.
    Hoffmann R; Jansen C; König A; Haager PK; Kerckhoff G; vom Dahl J; Klauss V; Hanrath P; Mudra H
    Eur Heart J; 2001 Nov; 22(21):2007-14. PubMed ID: 11603908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.
    Mishkel GJ; Aguirre FV; Ligon RW; Rocha-Singh KJ; Lucore CL
    J Am Coll Cardiol; 1999 Dec; 34(7):1884-90. PubMed ID: 10588198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
    Sekiguchi M; Hoshizaki H; Adachi H; Ohshima S; Taniguchi K; Kurabayashi M
    Circ J; 2004 Jul; 68(7):610-4. PubMed ID: 15226623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial.
    Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.